Cramer Diagnoses Quest Diagnostics (DGX)
Cramer’s last Fallen Angel on CNBC’s MAD MONEY tonight was Quest Diagnostics (DGX-NYSE). He owns it in his trust, for disclosure. He said that Quest losing Oxford’s business (Unitedhealth-UNH) took the stock down under $49.00 from over $53.00. The company…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cramer’s last Fallen Angel on CNBC’s MAD MONEY tonight was Quest Diagnostics (DGX-NYSE). He owns it in his trust, for disclosure. He said that Quest losing Oxford’s business (Unitedhealth-UNH) took the stock down under $49.00 from over $53.00. The company had already partially announced the news a month earlier if you looked at it (re-news). He isn’t minimizing the business loss, or so he says, because it was $400 million of their $6 Billion in total business. The company beat last week by $0.05 on EPS, but lowered guidance. He said it traded up $1.00 because the street is assuming it is conservative. He thinks it could earn $3.10 and they are low-balling estimates at $2.95. It closed at $52.25 and is now up at $52.90 in after-hours. J.P.Morgan just raised it and a broker luncheon on it last week was over-attended.
Jon C. Ogg
January 29, 2007
Contact [email protected] for any questions or corrections.

